Shenkang injection, a modern preparation of Chinese patent medicine, diminishes tubulointerstitial fibrosis in obstructive nephropathy via targeting pericyte-myofibroblast transition

Shenkang injection (SKI), a modern preparation of Chinese patent medicine, has been widely applied to clinical therapy in the chronic renal failure patients. However, it remains elusive whether SKI can ameliorate tubulointerstitial fibrosis (TIF) . Recently, pericyte-myofibroblast transition (PMT) p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of translational research 2019-01, Vol.11 (4), p.1980-1996
Hauptverfasser:	Liu, Yinglu, Shi, Ge, Yee, Hongyun, Wang, Wenwen, Han, Wenbei, Liu, Buhui, Wu, Wei, Tu, Yue, Ma, Qian, Huo, Dongqin, Wan, Ziyue, Cao, Dongwei, Wan, Yigang
Format:	Artikel
Sprache:	eng
Schlagworte:	Original
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!